Multibarrier-penetrating drug delivery systems for deep tumor therapy based on synergistic penetration strategy-Reference-Cited by-同舟云学术

Multibarrier-penetrating drug delivery systems for deep tumor therapy based on synergistic penetration strategy

Published:2024 Issue:9 Volume:12 Page:2321-2330
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Zhang Hui-Feng¹^ORCID,Yu Huan¹,Pan Shuang-Xue¹,Zhang Chuang¹,Ma Ying-Hui¹,Zhang Yan-Fei¹,Zuo Li-Li²,Hao Cheng-Yi¹,Lin Xiao-Ying¹,Geng Hao¹,Wu Di¹,Mu Shang-Qiang³,Yu Wei-Lun⁴,Shi Nian-Qiu¹⁵

Affiliation:

1. School of Pharmacy, Jilin Medical University, China

2. School of public health, Jilin Medical University, China

3. Affiliated hospital of Jilin Medical University, China

4. School of Bioengineering, Jilin Medical University, China

5. College of Pharmaceutical Sciences, Yanbian University, China

Abstract

We co-modified R9 and iNGR on the liposome surface to obtain Lip-mbPDS. The penetration of Lip-mbPDS into multiple biointerfaces has enabled it to demonstrate good anti-tumor ability for CD13-positive HT1080 cells both in vivo and ex vivo.

Funder

National Natural Science Foundation of China

Jilin Scientific and Technological Development Program

Education Department of Jilin Province

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/BM/D3BM01959D

Reference53 articles.

1. Artificial engineering of the protein corona at bio-nano interfaces for improved cancer-targeted nanotherapy

2. Liposomes: structure, composition, types, and clinical applications

3. Quantitative Evaluation of the Enhanced Permeability and Retention (EPR) Effect

4. Accumulating nanoparticles by EPR: A route of no return

5. The progress and perspective of strategies to improve tumor penetration of nanomedicines